Non-HIV antivirals Flashcards
Acyclovir MOA
2-deoxyguanosine analog; blocks NA synthesis
Acyclovir uses
Oral, IV, topical for HSV and VZV
Acyclovir metabolism and ADRs
Poor oral availability, short half-life renal excretion (reduce dose in renal failure) ADR: GI upset and HA, renal nephropathy d/t crystallization in tubules, pregnancy cat B
Valacyclovir
Oral prodrug of acyclovir for HSV, VZV
*better oral availability
pregnancy cat B
Famciclovir
oral prodrug of penciclovir
penciclovir
similar to ganciclovir
topical only for herpes labialis
nucleoside analogs used for CMV
ganciclovir
valganciclovir
ganciclovir
analog of nucleoside guanosine
given IV, MOA and metabolism like acyclovir
ADR ganciclovir
bone marrow suppression (50%), renal nephropathy, fever, HA
preg cat C
valganciclovir
prodrug of ganciclovir
oral; achieves same plasma level as IV ganciclovir
foscarnet
pyrophosphate analog that reversibly binds viral DNA polymerase
to treat CMV; alternative for HSV, resistant HSV, VZV
foscarnet metabolism and ADR
IV d/t poor oral availability; renal clearance proportional to creatinine clearance
ADR: renal tubular toxicity and crystallization (saline loading needed), seizures, hypocalcemia (binds free Ca), genital ulceration d/t high conc in urine
Cidofovir
monophosphate nucleotide analog of deoxycitidine (dCTP) for CMV in HIV patients unresponsive to ganciclovir or foscarnet tx
cidofovir metabolism & ADR
No viral kinase req for phosphorlyation
IV d/t poor oral availability
*Must give probenecid and saline before and after infusion to prevent renal tubular secretion and toxicity
ADR: nephrotoxicity and neutropenia
treatment strategies for HBV
life-long therapy to sustain suppression of HBV replication to slow progression of hepatic complications; no eradication